These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26526273)

  • 1. Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1H-indol-3-yl(adamantan-1-yl)methanone.
    Carlsson A; Lindberg S; Wu X; Dunne S; Josefsson M; Åstot C; Dahlén J
    Drug Test Anal; 2016 Oct; 8(10):1015-1029. PubMed ID: 26526273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018.
    Liu C; Jia W; Hua Z; Qian Z
    Drug Test Anal; 2017 Aug; 9(8):1251-1261. PubMed ID: 28063270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Naphthoylindazoles and 2-naphthoylbenzoimidazoles as novel chemical groups of synthetic cannabinoids: chemical structure elucidation, analytical characteristics and identification of the first representatives in smoke mixtures.
    Shevyrin V; Melkozerov V; Nevero A; Eltsov O; Morzherin Y; Shafran Y
    Forensic Sci Int; 2014 Sep; 242():72-80. PubMed ID: 25036783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CBL-2201. Report on a new designer drug: Napht-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate.
    Kondrasenko AA; Goncharov EV; Dugaev KP; Rubaylo AI
    Forensic Sci Int; 2015 Dec; 257():209-213. PubMed ID: 26386336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic cannabinoid 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole. The first detection in illicit market of new psychoactive substances.
    Shevyrin V; Melkozerov V; Eltsov O; Shafran Y; Morzherin Y
    Forensic Sci Int; 2016 Feb; 259():95-100. PubMed ID: 26771874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic cannabinoids as designer drugs: new representatives of indol-3-carboxylates series and indazole-3-carboxylates as novel group of cannabinoids. Identification and analytical data.
    Shevyrin V; Melkozerov V; Nevero A; Eltsov O; Baranovsky A; Shafran Y
    Forensic Sci Int; 2014 Nov; 244():263-75. PubMed ID: 25305529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UR-144 in products sold via the Internet: identification of related compounds and characterization of pyrolysis products.
    Kavanagh P; Grigoryev A; Savchuk S; Mikhura I; Formanovsky A
    Drug Test Anal; 2013 Aug; 5(8):683-92. PubMed ID: 23315949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and analytical characterization of four synthetic cannabinoids ADB-BICA, NNL-1, NNL-2, and PPA(N)-2201.
    Qian Z; Jia W; Li T; Hua Z; Liu C
    Drug Test Anal; 2017 Jan; 9(1):51-60. PubMed ID: 27239006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of new classes of recreational drugs in sewage: synthetic cannabinoids and amphetamine-like substances.
    Reid MJ; Derry L; Thomas KV
    Drug Test Anal; 2014; 6(1-2):72-9. PubMed ID: 23460377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct analysis in real time mass spectrometry with collision-induced dissociation for structural analysis of synthetic cannabinoids.
    Musah RA; Domin MA; Cody RB; Lesiak AD; Dane AJ; Shepard JR
    Rapid Commun Mass Spectrom; 2012 Oct; 26(19):2335-42. PubMed ID: 22956326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative "NE-CHMIMO" using flash chromatography, GC-MS, IR and NMR spectroscopy.
    Angerer V; Bisel P; Moosmann B; Westphal F; Auwärter V
    Forensic Sci Int; 2016 Sep; 266():e93-e98. PubMed ID: 27297324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GC-MS and GC-IR Analyses of the Methoxy-1-n-pentyl-3-(1-naphthoyl)-indoles: Regioisomeric Designer Cannabinoids.
    Thaxton-Weissenfluh A; Belal TS; DeRuiter J; Smith F; Abiedalla Y; Neel L; Abdel-Hay KM; Clark CR
    J Chromatogr Sci; 2018 Oct; 56(9):779-788. PubMed ID: 29920587
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Martek BA; Mihelač M; Gazvoda M; Virant M; Urankar D; Krivec M; Gostič T; Nemec B; Koštrun B; Janežič M; Klemenc S; Košmrlj J
    Drug Test Anal; 2019 Apr; 11(4):617-625. PubMed ID: 30730110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism.
    Hutter M; Moosmann B; Kneisel S; Auwärter V
    J Mass Spectrom; 2013 Jul; 48(7):885-94. PubMed ID: 23832945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE.
    Angerer V; Mogler L; Steitz JP; Bisel P; Hess C; Schoeder CT; Müller CE; Huppertz LM; Westphal F; Schäper J; Auwärter V
    Drug Test Anal; 2018 Mar; 10(3):597-603. PubMed ID: 28670781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of synthetic cannabinoid N-(adamantan-1-yl)-2-[1-(4- fluorobenzyl)-1H-indole-3-yl]acetamide].
    Mashchenko PS; Kataev SS; Mendogralo EY
    Sud Med Ekspert; 2023; 66(3):29-33. PubMed ID: 37192456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute kidney injury associated with smoking synthetic cannabinoid.
    Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
    Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: a snapshot of the German situation in the autumn of 2012.
    Langer N; Lindigkeit R; Schiebel HM; Ernst L; Beuerle T
    Drug Test Anal; 2014; 6(1-2):59-71. PubMed ID: 23723183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two thiazolylindoles and a benzimidazole: novel compounds on the designer drug market with potential cannabinoid receptor activity.
    Westphal F; Sönnichsen FD; Knecht S; Auwärter V; Huppertz L
    Forensic Sci Int; 2015 Apr; 249():133-47. PubMed ID: 25698514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products.
    Uchiyama N; Kikura-Hanajiri R; Ogata J; Goda Y
    Forensic Sci Int; 2010 May; 198(1-3):31-8. PubMed ID: 20117892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.